Executive Summary
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.
Under the product segment, Others is anticipated to witness a substantial market share owing to growing partnership among various pharmaceutical companies and leading CMOs which are helping in providing medicines, biologics delivery with advanced technology and efficient labour force backed with enhanced investment in expanding geographically, will be accelerating the Biopharmaceutical CMO market growth in the coming years.
Among the regions, Europe, followed by North America and Asia Pacific, will experience remarkable market share owing to presence of major countries including United Kingdom, Norway, Denmark, Switzerland that feature efficient healthcare system supported by ever growing number of patients. Rising need of developing medicine for many viruses coupled with growing mergers and acquisitions in the region between pharma companies and CMOs, will be propelling the Biopharmaceutical CMO market growth during the period of 2020-2025.
Scope of the Report
- The report analyses Biopharmaceutical CMO market By Value.
- The report analyses Biopharmaceutical CMO Market By Product Type (Microbial, and Others).
- The Global Biopharmaceutical CMO Market has been analysed By Region (North America, Europe, and Asia Pacific) and By Country (United States, Germany, Switzerland, Denmark, China, Japan, South Korea).
- The key insights of the report have been presented through the frameworks of Major mergers and acquisitions. Also, the attractiveness of the market has been presented By Region, and By Product Type. Additionally, the major opportunities, SWOT analysis, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Wuxi Biologics, Boehringer Ingelheim, Lonza, Samsung Biologics.
- The report presents the analysis of Biopharmaceutical CMO market for the historical period of 2015-2019 and the forecast period of 2020-2025.
Key Target Audience
- Biopharmaceutical CMO Vendors
- Pharmaceutical Companies
- Pharmaceutical Manufacturers
- Consulting and Advisory Firms
- Investment Banks and Equity Firms
Global Biopharmaceutical CMO Market - Analysis By Product Type (Microbial, Others) , By Region, By Country (2020 Edition) : Opportunities and Forecast (2020-2025) - By Region (N. America, Europe, APAC) , By Country (US, Germany, Switzerland, Denmark, China, Japan, South Korea)
Table of Contents
1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
2.1 Focus on Providing Quality and Reliability
2.2 Focus on Investing in Internal Factors
3. Biopharmaceutical CMO Market : Product Outlook
4. Global Biopharmaceutical CMO Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
5. Global Biopharmaceutical CMO Market Segmentation - By Product Type
5.1 Competitive Scenario of Global Biopharmaceutical CMO Market: By Product Type
5.1.1 Microbial - Market Size and Forecast (2015-2025)
5.1.2 Others - Market Size and Forecast (2015-2025)
6. Global Biopharmaceutical CMO Market: Regional Analysis
6.1 Competitive Scenario of Global Biopharmaceutical CMO Market : By Region
7. North America Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
7.1 North America Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
7.2 Market Segmentation By Product Type (Microbial, and Others)
7.3 North America Biopharmaceutical CMO Market: Country Analysis
7.5 Market Opportunity Chart of North America Biopharmaceutical CMO Market - By Country, By Value, 2025
7.6 Competitive Scenario of North America Biopharmaceutical CMO Market : By Country
7.7 United States Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
7.8 United States Biopharmaceutical CMO Market Segmentation - By Product Type
8. Europe Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
8.1 Europe Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.2 Market Segmentation By Product Type (Microbial, and Others)
8.3 Europe Biopharmaceutical CMO Market: Country Analysis
8.4 Market Opportunity Chart of Europe Biopharmaceutical CMO Market - By Country, By Value, 2025
8.5 Competitive Scenario of Europe Biopharmaceutical CMO Market : By Country
8.6 Germany Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.7 Germany Biopharmaceutical CMO Market Segmentation - By Product Type
8.8 Switzerland Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.9 Switzerland Biopharmaceutical CMO Market Segmentation - By Product Type
8.10 Denmark Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
8.11 Denmark Biopharmaceutical CMO Market Segmentation - By Product Type
9. Asia Pacific Biopharmaceutical CMO Market: Segmentation By Product Type (2015-2025)
9.1 Asia Pacific Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.2 Market Segmentation By Product Type (Microbial, and Others)
9.3 Asia Pacific Biopharmaceutical CMO Market: Country Analysis
9.4 Market Opportunity Chart of Asia Pacific Biopharmaceutical CMO Market - By Country, By Value, 2025
9.5 Competitive Scenario of Asia Pacific Biopharmaceutical CMO Market : By Country
9.6 China Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.7 China Biopharmaceutical CMO Market Segmentation - By Product Type
9.8 Japan Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.9 Japan Biopharmaceutical CMO Market Segmentation - By Product Type
9.10 South Korea Biopharmaceutical CMO Market: Size and Forecast (2015-2025), By Value
9.11 South Korea Biopharmaceutical CMO Market Segmentation - By Product Type
10. Global Biopharmaceutical CMO Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Product Type, 2025
11.3 Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Region, 2025
12. Strategic Analysis and Competitive Landscape
12.1 SWOT Analysis
12.2 Major Technological Innovations and Mergers & Acquisitions
12.3 Market Share Analysis
13. Company Analysis
13.1 Lonza
13.2 Boehringer Ingelheim
13.3 Samsung Biologics
13.4 Wuxi Biologics
List of Figures
Figure 1: Global Bio CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Global Biologics market Outlook, 2012, 2016, 2021 (In Billion )
Figure 3: Global Biologics market Outlook, By Countries, 2019 (In Billion)
Figure 4: Global Healthcare Expenditure, 2012-2016 (In Trillion)
Figure 5: Global Biopharmaceutical CMO Market, By Product Type, 2019, 2025
Figure 6: Global Biopharmaceutical CMO Market - By Microbial, By Value (USD Million), 2015-2025
Figure 7: Global Biopharmaceutical CMO Market - By Others, By Value (USD Million), 2015-2025
Figure 8: Global Biopharmaceutical CMO Market, By Region, 2019, 2025
Figure 9: North America Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 10: North America GDP, 2014-2017 (USD Trillion)
Figure 11: North America GDP, By Select Country, 2018 (USD Trillion)
Figure 12: North America Healthcare Cost Per Capita, By Select Country, 2018 (USD)
Figure 13: Number of Citizen 65 years and above, USA and Canada in Million 2018
Figure 14: Number of Citizen 65 years and above, USA and Canada in Million 2060
Figure 15: North America Prevalence of Gynecological Disorders (2014-2016)
Figure 16: Total Number of People with North America Neglected Tropical Disorders (2014-2016)
Figure 17: Total Number of People in North America with Different Type of Cardiovascular Disease in 2018
Figure 18: North America DALYs of Ischemic Heart Disease (2014-2016 %)
Figure 19: North America DALYs of Chronic Kidney Disease (2014-2017 %)
Figure 20: North America DALYs of Chronic Obstructive Pulmonary Disease (2014-2017 %)
Figure 21: North America DALYs of Alzheimer Disease and Other Dementias (2014-2017 %)
Figure 22: North America DALYs of Diabetes Mellitus (2014-2017 %)
Figure 23: North America Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 24: Market Opportunity Chart of North America Biopharmaceutical CMO Market - By Country, By Value, 2025
Figure 25: North America Biopharmaceutical CMO Market, By Country, 2019, 2025
Figure 26: United States Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 27: United States Prevalence of Diabetes (Per 1,00,000 )2014-2017
Figure 28: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2014-2017
Figure 29: Prevalence of Neurological Disorders in United States (2016, Million)
Figure 30: United States Prevalence of Cardiovascular Disorders (Per 1,00,000) 2014-2017
Figure 31: United States DALYs of Ischemic Heart Disease (2014-2017 %)
Figure 32: United States DALYs of Chronic Kidney Disease(2014-2017 %)
Figure 33: United States DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %)
Figure 34: United States DALYs of Alzheimer Disease and Other Dementias (2014-2017 %)
Figure 35: United States DALYs of Diabetes Mellitus (2014-2017 %)
Figure 36: United States Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 37: Europe Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 38: Number Of Deaths due to cancer in Europe, 2017
Figure 39: Share of older population 65 years and above as percentage of total population, 2017
Figure 40: Europe Prevalence of Gynecological (2014-2017, Million)
Figure 41: Europe Prevalence of Musculoskeletal Disorders (2014-2017, Million)
Figure 42: Total Number of People With Cardiovascular Disorders in Europe, By Type, 2017
Figure 43: Europe DALYs of Ischemic Heart Disease (2014-2017), in %
Figure 44: Europe DALYs of Chronic Kidney Disease(2014-2017)in %
Figure 45: Europe DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %)
Figure 46: Europe DALYs of Alzheimer Disease and Other Dementias (2014-2017 )in %
Figure 47: Europe DALYs of Diabetes Mellitus (2014-2017 )in %
Figure 48: Europe Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 49: Market Opportunity Chart of Europe Biopharmaceutical CMO Market - By Country, By Value, 2025
Figure 50: Europe Biopharmaceutical CMO Market, By Country, 2019, 2025
Figure 51: Germany Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 52: Germany DALYs of Ischemic Heart Disease (2014-2017), in %
Figure 53: Germany DALYs of Chronic Kidney Disease (2014-2017), in %
Figure 54: Germany DALYs of Chronic Obstructive Pulmonary Disease(2014-2017), in%
Figure 55: Germany DALYs of Alzheimer Disease and Other Dementias (2014-2017), %
Figure 56: Germany DALYs of Diabetes Mellitus (2014-2017), %
Figure 57: Germany Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 58: Switzerland Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 59: Switzerland Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017
Figure 60: Total Number of People With Infectious Disorder in Switzerland (2014-2017), In thousands
Figure 61: Switzerland Prevalence of Neurological Disorders (2014-2017, Million)
Figure 62: Switzerland Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions)
Figure 63: Switzerland Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 64: Denmark Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 65: Denmark Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017
Figure 66: Total Number of People With Infectious Disorder in Denmark (2014-2017), In thousands
Figure 67: Denmark Prevalence of Neurological Disorders (2014-2017, Million)
Figure 68: Denmark Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions)
Figure 69: Denmark Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 70: Asia Pacific Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 71: Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2014-2017 %)
Figure 72: Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2014-2017 %)
Figure 73: Asia, East Asia, Oceania DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %)
Figure 74: Asia, East Asia, Oceania DALYs of Alzheimer Disease and Other Dementias (2014-2017 %)
Figure 75: Asia, East Asia, Oceania DALYs of Diabetes Mellitus (2014-2017 %)
Figure 76: Asia Pacific Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 77: Market Opportunity Chart of Asia Pacific Biopharmaceutical CMO Market - By Country, By Value, 2025
Figure 78: Asia Pacific Biopharmaceutical CMO Market, By Country, 2019, 2025
Figure 79: China Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 80: China DALYs of Ischemic Heart Disease (2014-2017 %)
Figure 81: China DALYs of Chronic Kidney Disease(2014-2017 %)
Figure 82: China DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %)
Figure 83: China DALYs of Alzheimer Disease and Other Dementias (2014-2017 %)
Figure 84: China DALYs of Diabetes Mellitus (2014-2017 %)
Figure 85: China Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 86: Japan Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 87: Japan DALYs of Ischemic Heart Disease (2014-2017 %)
Figure 88: Japan DALYs of Chronic Kidney Disease(2014-2017 %)
Figure 89: Japan DALYs of Chronic Obstructive Pulmonary Disease(2014-2017 %)
Figure 90: Japan DALYs of Alzheimer Disease and Other Dementias (2014-2017 %)
Figure 91: Japan DALYs of Diabetes Mellitus(2014-2017 %)
Figure 92: Japan Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 93: South Korea Biopharmaceutical CMO Market Size, By Value, 2015-2025 (USD Million)
Figure 94: South Korea Prevalence of Musculoskeletal Disorders (In Millions), 2014-2017
Figure 95: Total Number of People With Infectious Disorder in South Korea (2014-2017), In thousands
Figure 96: South Korea Prevalence of Neurological Disorders (2014-2017, Million)
Figure 97: South Korea Prevalence of Cardiovascular Disorders, 2014-2017 (In Millions)
Figure 98: South Korea Biopharmaceutical CMO Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 99: Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Product Type, 2025
Figure 100: Market Attractiveness Chart of Global Biopharmaceutical CMO Market - By Region, By Value, 2025
Figure 101: Market Share of Leading Global Biopharmaceutical CMO Companies, 2019 (In %)
Figure 102: Lonza, Net Sales, 2014-2017 (In Billion USD)
Figure 103: Boehringer Ingelheim, Net Sales, 2014-2016 (In Million USD)
Figure 104: Boehringer Ingelheim Sales by Region, 2016
Figure 105: Boehringer Ingelheim Sales by Segment, 2016Boehringer Ingelheim Sales by Segment, 2016
Figure 106: Samsung Biologics, Net Sales, 2014-2018 (In Million USD)
Figure 107: Samsung Biologics, Biomedicine manufacturing plants, 2017
Figure 108: Wuxi Biologics, Net Sales, 2014 - 2018 (In Million USD)
Figure 109: Wuxi Biologics, Sales by Region, 2018
Figure 110: Wuxi Biologics Sales by Region, 2017
List of Tables
Table A: A Brief Comparison Between Chemicals and Biologics
Table B: Number of people with diabetes worldwide and per region in 2017 and 2045, (20-79 years)
Table C: Diabetes Prevalence, By Country, in % of population ages 20 to 79 in 2017
Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 118
Market Overview of Global Bio-Pharma market:
According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
Global Bio-pharma Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 91
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Pfizer
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services
- Sanofi, Amgen
- AbbVie
- Merck & Co., Inc
- Biogen Idec
- Bayer AG
- E......
Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
Published: 24-Nov-2023 Price: US 4950 Onwards Pages: 273
“Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.”
The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
Published: 20-Nov-2023 Price: US 3280 Onwards Pages: 139
A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
Published: 20-Nov-2023 Price: US 2680 Onwards Pages: 160
A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
Published: 18-Sep-2023 Price: US 2500 Onwards Pages: 85
This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Biopharmaceutic......
Global Bio-pharma Market Insights, Forecast to 2029
Published: 10-Aug-2023 Price: US 4900 Onwards Pages: 108
The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
Biopharmaceuticals Markets in China
Published: 24-Jul-2023 Price: US 4000 Onwards Pages: 233
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
